Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

4.3K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

506
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
506
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.8K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.8K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

9.0K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.0K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

49
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
49
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

46
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
46

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KLF4 Promotes a KRT13+ Hillock-Like State in Lung Squamous Cell Carcinoma.

Cancer research·2026
Same author

Heterogeneous, population-level drug-tolerant persisters exhibit ion-channel remodeling and ferroptosis susceptibility.

bioRxiv : the preprint server for biology·2026
Same author

A Computational Model of Tumor Interactions with Bone-Resident Cells Predicts Tumor-Type-Specific Responses to Perturbations.

bioRxiv : the preprint server for biology·2026
Same author

Capturing Multi-Scale Dynamics of Aortic Valve Calcification With a Coupled Fluid-Structure and Systems Biology Model.

bioRxiv : the preprint server for biology·2026
Same author

Small cell lung cancer induces synaptic scaling to alter neuronal excitability.

Communications biology·2025
Same author

A Roadmap for the Future of Systems Biology in Cancer Research.

Cancer research·2025

Related Experiment Video

Updated: Nov 4, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.4K

Thunor: visualization and analysis of high-throughput dose-response datasets.

Alexander L R Lubbock1, Leonard A Harris2,3,4, Vito Quaranta1,5

  • 1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.

Nucleic Acids Research
|May 26, 2021
PubMed
Summary

A new open-source software platform, Thunor, manages, analyzes, and visualizes large cell proliferation datasets. It offers interactive tools for reproducible drug-response analysis, aiding research in cancer and other diseases.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.8K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.3K

Related Experiment Videos

Last Updated: Nov 4, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.4K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.8K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.3K

Area of Science:

  • Pharmacology
  • Bioinformatics
  • Computational Biology

Background:

  • High-throughput cell proliferation assays are crucial for drug response quantification.
  • Existing analysis pipelines lack reproducibility, efficiency, and interactive visualization.
  • Need for a robust platform to manage and interpret large-scale proliferation data.

Purpose of the Study:

  • Introduce Thunor, an open-source software platform for managing, analyzing, and visualizing cell proliferation data.
  • Provide a user-friendly interface for interactive exploration of dose-dependent drug responses.
  • Facilitate reproducible research through enhanced data interpretation and sharing.

Main Methods:

  • Developed Thunor, an open-source software platform supporting end-point and time-based proliferation assays.
  • Integrated interactive plotting for time courses, dose-response curves, and IC50 metrics.
  • Implemented a graphical plate map tool for data annotation and tag-based aggregation.

Main Results:

  • Thunor effectively manages and analyzes large, dose-dependent cell proliferation datasets.
  • Interactive visualizations enable clear interpretation of drug response metrics (e.g., IC50).
  • Demonstrated utility with public cell viability and in-house proliferation rate datasets.

Conclusions:

  • Thunor addresses the need for a comprehensive, user-friendly platform for cell proliferation assay analysis.
  • The software enhances reproducibility and facilitates deeper insights into drug response.
  • Thunor is a valuable tool for researchers working with high-throughput drug screening data.